The Enterprise Value as of December 2025 (TTM) for Acrivon Therapeutics, Inc. Common Stock (ACRV) is 43.63M

According to Acrivon Therapeutics, Inc. Common Stock’s latest financial reports and current stock price. The company's current Enterprise Value is 43.63M. This represents a change of -37.84% compared to the average of 70.19M of the last 4 quarters.

Acrivon Therapeutics, Inc. Common Stock (ACRV) Historical Enterprise Value (quarterly & annually)

How has ACRV Enterprise Value performed in the past?

The mean historical Enterprise Value of Acrivon Therapeutics, Inc. Common Stock over the last ten years is 582.40M. The current 43.63M Enterprise Value has changed 649.17% with respect to the historical average. Over the past ten years (40 quarters), ACRV's Enterprise Value was at its highest in in the September 2022 quarter at 286.05M. The Enterprise Value was at its lowest in in the September 2021 quarter at 0.

Acrivon Therapeutics, Inc. Common Stock (ACRV) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Acrivon Therapeutics, Inc. Common Stock Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Acrivon Therapeutics, Inc. Common Stock (ACRV) Average Enterprise Value

How has ACRV Enterprise Value performed in the past?

The current Enterprise Value of Acrivon Therapeutics, Inc. Common Stock (ACRV) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Acrivon Therapeutics, Inc. Common Stock (ACRV) Enterprise Value vs. Peers

How is ACRV’s Enterprise Value compared to its peers?

Acrivon Therapeutics, Inc. Common Stock’s Enterprise Value is greater than PMV Pharmaceuticals, Inc. (25.00M), less than Relmada Therapeutics, Inc. (291.98M), less than Vaxart, Inc. (87.39M), greater than Immunic, Inc. (32.92M), greater than Repare Therapeutics Inc. (23.36M), greater than TScan Therapeutics, Inc. (-43127305.00), less than aTyr Pharma, Inc. (87.32M), less than Cibus, Inc. (94.92M), greater than Biomea Fusion, Inc. (31.03M), less than Unicycive Therapeutics, Inc. (72.37M),

Build a custom stock screener for Acrivon Therapeutics, Inc. Common Stock (ACRV) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acrivon Therapeutics, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Acrivon Therapeutics, Inc. Common Stock (ACRV) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Acrivon Therapeutics, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.